PLx Pharma Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and PLx Pharma are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days PLx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, PLx Pharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 22.4 M | |
| Total Cashflows From Investing Activities | 95 K |
PLx |
PLx Pharma Relative Risk vs. Return Landscape
If you would invest (100.00) in PLx Pharma on October 2, 2025 and sell it today you would earn a total of 100.00 from holding PLx Pharma or generate -100.0% return on investment over 90 days. PLx Pharma is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than PLx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PLx Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PLx Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PLx Pharma, and traders can use it to determine the average amount a PLx Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PLXP |
Based on monthly moving average PLx Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PLx Pharma by adding PLx Pharma to a well-diversified portfolio.
PLx Pharma Fundamentals Growth
PLx Stock prices reflect investors' perceptions of the future prospects and financial health of PLx Pharma, and PLx Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PLx Stock performance.
| Return On Equity | -0.75 | |||
| Return On Asset | -0.64 | |||
| Operating Margin | (14.18) % | |||
| Current Valuation | 5.49 M | |||
| Shares Outstanding | 29.14 M | |||
| Price To Earning | 52.40 X | |||
| Price To Book | 0.58 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 8.21 M | |||
| EBITDA | (35.24 M) | |||
| Cash And Equivalents | 35.73 M | |||
| Cash Per Share | 1.27 X | |||
| Total Debt | 202 K | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 0.35 X | |||
| Cash Flow From Operations | (32.12 M) | |||
| Earnings Per Share | (0.39) X | |||
| Total Asset | 76.64 M | |||
| Retained Earnings | (148.27 M) | |||
| Current Asset | 13.62 M | |||
| Current Liabilities | 2.4 M | |||
Things to note about PLx Pharma performance evaluation
Checking the ongoing alerts about PLx Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PLx Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PLx Pharma is not yet fully synchronised with the market data | |
| PLx Pharma has some characteristics of a very speculative penny stock | |
| PLx Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.21 M. Net Loss for the year was (46.12 M) with profit before overhead, payroll, taxes, and interest of 3.4 M. | |
| PLx Pharma currently holds about 35.73 M in cash with (32.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.27. | |
| Roughly 15.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing PLx Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PLx Pharma's stock is overvalued or undervalued compared to its peers.
- Examining PLx Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PLx Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PLx Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PLx Pharma's stock. These opinions can provide insight into PLx Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in PLx Stock
If you are still planning to invest in PLx Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PLx Pharma's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |